428 related articles for article (PubMed ID: 16185234)
21. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.
Fischer P; Tukesiga E; Büttner DW
J Infect Dis; 1999 Oct; 180(4):1403-5. PubMed ID: 10479183
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
[TBL] [Abstract][Full Text] [Related]
23. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
Plaisier AP; Stolk WA; van Oortmarssen GJ; Habbema JD
Parasitol Today; 2000 Jul; 16(7):298-302. PubMed ID: 10858649
[TBL] [Abstract][Full Text] [Related]
25. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Krishnamoorthy K; Rajendran R; Sunish IP; Reuben R
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S77-90. PubMed ID: 12625921
[TBL] [Abstract][Full Text] [Related]
27. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
[TBL] [Abstract][Full Text] [Related]
28. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
29. Lymphatic filariasis in Uganda: baseline investigations in Lira, Soroti and Katakwi districts.
Onapa AW; Simonsen PE; Pedersen EM; Okello DO
Trans R Soc Trop Med Hyg; 2001; 95(2):161-7. PubMed ID: 11355548
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic filariasis and onchocerciasis.
Taylor MJ; Hoerauf A; Bockarie M
Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
[TBL] [Abstract][Full Text] [Related]
31. Filaria control and elimination: diagnostic, monitoring and surveillance needs.
Molyneux DH
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357
[TBL] [Abstract][Full Text] [Related]
32. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.
Plaisier AP; Alley ES; van Oortmarssen GJ; Boatin BA; Habbema JD
Bull World Health Organ; 1997; 75(3):237-45. PubMed ID: 9277011
[TBL] [Abstract][Full Text] [Related]
33. Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
Mnkai J; Marandu TF; Mhidze J; Urio A; Maganga L; Haule A; Kavishe G; Ntapara E; Chiwerengo N; Clowes P; Horn S; Mosoba M; Lazarus W; Ngenya A; Kalinga A; Debrah A; Rieß F; Saathoff E; Geldmacher C; Hoerauf A; Hoelscher M; Chachage M; Kroidl I
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010044. PubMed ID: 35857778
[TBL] [Abstract][Full Text] [Related]
34. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas.
Shiferaw W; Kebede T; Graves PM; Golasa L; Gebre T; Mosher AW; Tadesse A; Sime H; Lambiyo T; Panicker KN; Richards FO; Hailu A
Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):117-27. PubMed ID: 22154976
[TBL] [Abstract][Full Text] [Related]
35. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
37. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
[TBL] [Abstract][Full Text] [Related]
38. Modelling the epidemiology, transmission and control of lymphatic filariasis.
Das PK; Subramanian S
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
[TBL] [Abstract][Full Text] [Related]
39. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with
Dolo H; Coulibaly YI; Kelly-Hope L; Konate S; Dembele B; Coulibaly SY; Sanogo D; Soumaoro L; Coulibaly ME; Doumbia SS; Diallo AA; Traore SF; Colebunders R; Nutman TB; Klion AD
Am J Trop Med Hyg; 2018 Jun; 98(6):1782-1787. PubMed ID: 29714157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
